21.12.2022 Views

Feng, Xiaodong_ Xie, Hong-Guang - Applying pharmacogenomics in therapeutics-CRC Press (2016)

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Pharmacogenomics and Laboratory Medicine

131

is to analyze the whole exome and whole genome sequence to assess interpatient

variability in drug response and side effects and discover novel targets for personalized

therapy. In recognition of the importance of pharmacogenomics and revolution

of personalized medicine, the Obama administration recently unveiled the Precision

Medicine Initiative to improve health and treat disease. * Pharmacogenomics will

shed light on producing more powerful drugs by targeting specific diseases with

maximized therapeutic effects and minimized side effects. Appropriate drug doses

will be determined by pharmacogenomics based on a patient’s genetic makeup in

addition to his or her body weight and age. In the near future, pharmacogenomics

will make the dream of precision medicine a reality.

STUDY QUESTIONS

1. What percentage of differences in drug efficacy and adverse effect is due to

genetics?

a. 5%

b. 10%

c. 20–95%

d. 100%

2. What are single nucleotide polymorphisms (SNPs)? How many SNPs are

there in human genomes?

3. How many metabolizer groups are in the CYP2D6 gene?

4. Give one example of a drug metabolized by thiopurine methyltransferase

(TPMT)?

5. What does a drug transporter do?

6. What is a Philadelphia chromosome? What is the fusion gene on a Ph

chromosome?

7. What is the gold standard test to detect ALK rearrangement?

8. List the two most common mutations in EGFR that are responsible for

about 90% of NSCLC cases?

9. Germline mutations of which genes cause hereditary breast–ovarian cancer

(HBOC) syndrome?

Answers

1. c

2. SNPs are the most common form of polymorphisms, defined as the occurrence

at an allele frequency of at least 1/1000 bases in the general population.

There are an estimated 1.4 million SNPs in the human genome.

3. Four. Poor metabolizer, intermediate metabolizer, ultrarapid metabolizer,

and extensive metabolizer.

4. 6-Mercaptopurine is used to treat acute lymphoblastic leukemia of

childhood.

5. To transport drug across the cell membrane.

* https://www.whitehouse.gov/the-press-office/2015/01/30/fact-sheet- president-obama-s-precisionmedicine-initiative

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!